| Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer SA Tomlins, DR Rhodes, S Perner, SM Dhanasekaran, R Mehra, XW Sun, ... science 310 (5748), 644-648, 2005 | 4814 | 2005 |
| UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses DS Chandrashekar, B Bashel, SAH Balasubramanya, CJ Creighton, ... Neoplasia 19 (8), 649-658, 2017 | 4750 | 2017 |
| The polycomb group protein EZH2 is involved in progression of prostate cancer S Varambally, SM Dhanasekaran, M Zhou, TR Barrette, C Kumar-Sinha, ... Nature 419 (6907), 624-629, 2002 | 3270 | 2002 |
| Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression A Sreekumar, LM Poisson, TM Rajendiran, AP Khan, Q Cao, J Yu, ... Nature 457 (7231), 910-914, 2009 | 2474 | 2009 |
| Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles DR Rhodes, S Kalyana-Sundaram, V Mahavisno, R Varambally, J Yu, ... Neoplasia 9 (2), 166-180, 2007 | 2249 | 2007 |
| Delineation of prognostic biomarkers in prostate cancer SM Dhanasekaran, TR Barrette, D Ghosh, R Shah, S Varambally, ... Nature 412 (6849), 822-826, 2001 | 2152 | 2001 |
| EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells CG Kleer, Q Cao, S Varambally, R Shen, I Ota, SA Tomlins, D Ghosh, ... Proceedings of the national academy of sciences 100 (20), 11606-11611, 2003 | 1983 | 2003 |
| Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer H Beltran, D Prandi, JM Mosquera, M Benelli, L Puca, J Cyrta, C Marotz, ... Nature medicine 22 (3), 298-305, 2016 | 1421 | 2016 |
| Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer S Varambally, Q Cao, RS Mani, S Shankar, X Wang, B Ateeq, B Laxman, ... science 322 (5908), 1695-1699, 2008 | 1343 | 2008 |
| An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression J Yu, J Yu, RS Mani, Q Cao, CJ Brenner, X Cao, X Wang, L Wu, J Li, M Hu, ... Cancer cell 17 (5), 443-454, 2010 | 1014 | 2010 |
| Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer SA Tomlins, B Laxman, SM Dhanasekaran, BE Helgeson, X Cao, ... Nature 448 (7153), 595-599, 2007 | 1004 | 2007 |
| Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression S Varambally, J Yu, B Laxman, DR Rhodes, R Mehra, SA Tomlins, ... Cancer cell 8 (5), 393-406, 2005 | 892 | 2005 |
| α-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer MA Rubin, M Zhou, SM Dhanasekaran, S Varambally, TR Barrette, ... Jama 287 (13), 1662-1670, 2002 | 890 | 2002 |
| Role of the TMPRSS2-ERG gene fusion in prostate cancer SA Tomlins, B Laxman, S Varambally, X Cao, J Yu, BE Helgeson, Q Cao, ... Neoplasia 10 (2), 177-IN9, 2008 | 888 | 2008 |
| UALCAN: An update to the integrated cancer data analysis platform DS Chandrashekar, SK Karthikeyan, PK Korla, H Patel, AR Shovon, ... Neoplasia 25, 18-27, 2022 | 812 | 2022 |
| Autoantibody signatures in prostate cancer X Wang, J Yu, A Sreekumar, S Varambally, R Shen, D Giacherio, R Mehra, ... New England Journal of Medicine 353 (12), 1224-1235, 2005 | 756 | 2005 |
| Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program RB Shah, R Mehra, AM Chinnaiyan, R Shen, D Ghosh, M Zhou, ... Cancer research 64 (24), 9209-9216, 2004 | 729 | 2004 |
| Repression of E-cadherin by the polycomb group protein EZH2 in cancer Q Cao, J Yu, SM Dhanasekaran, JH Kim, RS Mani, SA Tomlins, R Mehra, ... Oncogene 27 (58), 7274-7284, 2008 | 658 | 2008 |
| Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma N Palanisamy, B Ateeq, S Kalyana-Sundaram, D Pflueger, ... Nature medicine 16 (7), 793-798, 2010 | 550 | 2010 |
| Probabilistic model of the human protein-protein interaction network DR Rhodes, SA Tomlins, S Varambally, V Mahavisno, T Barrette, ... Nature biotechnology 23 (8), 951-959, 2005 | 535 | 2005 |
